Navigating the New Era of Nasal Drug Delivery

Session details:

Nasal drug delivery is creating new opportunities in systemic therapies targeted at the central nervous system, and innovative nose-to-brain applications. However, innovation comes with significant formulation, device, manufacturing and regulatory challenges. Success depends on more than reaching the clinic—it requires a development pathway that can scale efficiently through to commercial supply. This session explores what sponsors should look for in a nasal delivery partner, including integrated device-drug development, risk mitigation, technical expertise and regulatory readiness. Attendees will gain practical insights into de-risking programmes, accelerating timelines and ensuring their nasal therapies have the best chance of reaching patients successfully.